http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20160008293-A
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d54dc581d1dc14fa58797d2d8be56e79 |
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2250-21 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2002-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2200-30 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-21 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-105 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-185 |
filingDate | 2014-07-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_27e649e944aa6891465a5f14811fbaea http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f0a3c4c12ef9678075fc14a2d501ff77 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_aa3aad6b40479b5e2be9c15aac2d087d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e19d3c0f86ac44408a83cc8a4b8be775 |
publicationDate | 2016-01-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | KR-20160008293-A |
titleOfInvention | A composition comprising extracts of halophyte salsola komarovi iljin for preventing, improving or treating gastrointestinal disorder |
abstract | The present invention relates to a composition for preventing, ameliorating or treating a gastrointestinal disorder containing an extract of a natural plant-borne herb as an active ingredient. More particularly, the present invention relates to a pharmaceutical composition for preventing or treating acute gastritis, chronic gastritis, gastric ulcer, gastric ulcer, duodenal ulcer, gastric cancer, intestinal obstruction, acute gastrointestinal bleeding, Crohn's disease, ulcerative colitis, Ameliorating or treating gastrointestinal disorders, including gastrointestinal disorders. The composition according to the present invention reduces the clinical symptoms, inhibits gastric mucosal damage, increases gastric lesion inhibition rate, decreases pathological tissue lesions, inhibits villous epithelial cell damage and lesions, It has efficacy. |
isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-115381887-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-115381887-B |
priorityDate | 2014-07-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 74.